玩股撇步(動畫小學堂)  

  • 營業利益和稅後淨利成長率大於營收成長率, 通常代表公司在成長, 如果是漲很多的股票, 發現沒有這個現象就要留意了
  • 營收到某個數字後, 營業利益產生不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)440.04.76-2.49-5080.0-536.840.951155.56480.0-1.81-366.18-6133.330.53-11.67178.9519.32-44.59-61.8-0.08-500.0-33.33-1.1-5600.0-558.33-300.61-2524.27-294.24-296.62-3793.9-328.34-8.96-2587.03609.78
23Q3 (19)440.00.00.05-94.05-16.67-0.0964.035.710.687.94223.640.6-6.25114.2934.87-24.26-24.990.020.0140.00.02-94.59-33.3312.40-84.24-13.598.03-89.65-12.627.25202.97-31.63
23Q2 (18)440.02.330.84500.0380.0-0.25-127.27-38.890.63400.0198.440.6420.75190.9146.0460.1416.090.02150.0122.220.37511.11384.6278.66658.27220.3377.57636.45228.6699.85181.58-35.63
23Q1 (17)444.7615.79-0.21-136.8436.36-0.1156.0-22.22-0.21-800.036.360.53178.95211.7628.75-43.16-50.11-0.0433.330.0-0.09-137.530.77-14.09-109.181.83-14.46-111.1380.1573.41356.58-11.28
22Q4 (16)42-4.5535.480.57850.035.71-0.25-78.57-56.250.03105.45-97.170.19-32.14-17.3950.588.8-8.37-0.06-20.00.00.24700.084.62154.76978.47159.84129.901313.49134.43-2.44485.00-28.17
22Q3 (15)442.3346.670.06120.0-83.33-0.1422.22-600.0-0.5514.06-182.090.2827.2716.6746.4917.2216.2-0.0544.44-150.00.03123.08-72.7314.35121.95-66.089.19115.24-79.5828.3464.55-38.89
22Q2 (14)4313.1643.33-0.309.09-168.18-0.18-100.0-212.5-0.64-93.94-306.450.2229.41-37.1439.66-31.18-12.18-0.09-125.0-181.82-0.130.0-200.0-65.3715.68-232.46-60.2917.22-234.851.66-84.74-28.12
22Q1 (13)3822.5826.67-0.33-178.57-153.85-0.0943.75-550.0-0.33-131.13-153.850.17-26.09-22.7357.634.4-18.83-0.0433.33-100.0-0.13-200.0-225.0-77.53-230.17-155.87-72.83-231.44-171.96-15.13-80.95-328.12
21Q4 (12)313.336.90.4216.67231.25-0.16-700.0-220.01.0658.21215.220.23-4.17-37.8455.2037.97-17.97-0.06-200.0-500.00.1318.18244.4459.5640.77376.1255.4123.11353.59-17.80-0.75-406.25
21Q3 (11)300.03.450.36-18.18238.46-0.02-112.581.820.67116.13211.670.24-31.43-38.4640.01-11.4-46.28-0.02-118.180.00.11-15.38237.542.31-14.27454.9545.010.67580.3613.83210.14293.75
21Q2 (10)300.03.450.44438.46276.00.16700.0180.00.31338.46191.180.3559.09-14.6345.16-36.39-28.780.11650.0283.330.13425.0285.7149.35262.87558.2244.71266.95491.519.28248.92420.00
21Q1 (9)303.453.45-0.1359.38-44.440.02140.0140.0-0.1385.87-44.440.22-40.54-15.3871.005.51-5.46-0.02-100.0-300.0-0.0455.56-33.33-30.30-40.47-6686.96-26.78-22.56-744.79-22.8418.1597.28
20Q4 (8)290.07.41-0.32-23.08-357.14-0.0554.5528.57-0.92-53.33-50.820.37-5.1348.067.29-9.65-0.37-0.0150.0-200.0-0.09-12.5-350.0-21.57-80.96-519.65-21.85-133.19-420.38-5.00-13.5449.77
20Q3 (7)290.07.41-0.26-4.0-44.44-0.1145.00.0-0.60-76.47-11.110.39-4.88254.5574.4817.46135.1-0.0266.6766.67-0.08-14.29-60.0-11.92-10.6877.8-9.3717.9578.0626.40-90.89-127.50
20Q2 (6)290.07.41-0.25-177.78-31.58-0.20-300.0-122.22-0.34-277.785.560.4157.69355.5663.41-15.5729.62-0.06-700.0-20.0-0.07-133.33-40.0-10.77-2441.383.37-11.42-260.2578.8930.84-103.17-135.72
20Q1 (5)297.417.41-0.09-28.5747.06-0.0528.5754.55-0.0985.2547.060.264.044.4475.1011.19239.970.010.0120.0-0.03-50.040.00.46-91.05101.74-3.17-146.4887.52--0.00
19Q4 (4)270.00.0-0.0761.110.0-0.0736.360.0-0.61-12.960.00.25127.270.067.54113.190.00.01116.670.0-0.0260.00.05.14109.570.06.82115.970.0--0.00
19Q3 (3)270.00.0-0.185.260.0-0.11-22.220.0-0.54-50.00.00.1122.220.031.68-35.240.0-0.06-20.00.0-0.050.00.0-53.6917.080.0-42.7121.070.0--0.00
19Q2 (2)270.00.0-0.19-11.760.0-0.0918.180.0-0.36-111.760.00.09-50.00.048.92121.460.0-0.050.00.0-0.050.00.0-64.75-145.450.0-54.11-113.030.0--0.00
19Q1 (1)270.00.0-0.170.00.0-0.110.00.0-0.170.00.00.180.00.022.090.00.0-0.050.00.0-0.050.00.0-26.380.00.0-25.400.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/20.05-63.78-74.330.19-24.80.38N/A因遇春節連假,交易日減少,故收入比去年同期減少
2024/10.14-29.03149.690.14149.690.54N/A因本期增加合併子公司營收,故比去年同期增加
2023/120.19-7.58133.72.31171.360.530.43因本期增加合併子公司營收,故比去年同期增加
2023/110.2160.99329.932.12175.420.540.42因本期增加合併子公司營收,故比去年同期增加
2023/100.13-36.43135.831.91164.960.550.41因本期增加合併子公司營收,故比去年同期增加
2023/90.2-6.86315.881.78167.380.60.31因本期增加合併子公司營收,故比去年同期增加
2023/80.2222.2180.061.57155.50.530.36因本期增加合併子公司營收,故比去年同期增加
2023/70.1834.4320.461.35151.910.560.34因本期增加合併子公司營收,故比去年同期增加
2023/60.13-45.9644.221.17202.540.630.29因本期增加合併子公司營收,故比去年同期增加
2023/50.250.32191.261.04252.340.790.23因本期增加合併子公司營收,故比去年同期增加
2023/40.25-16.54551.570.79277.080.740.24因本期增加合併子公司營收,故比去年同期增加
2023/30.352.55423.330.54216.630.540.39因本期增加合併子公司營收,故比去年用期增加
2023/20.19252.32267.620.25115.490.330.63因本期增加合併子公司營收,故比去年同期增加
2023/10.06-33.57-12.320.06-12.320.191.13-
2022/120.0870.0-12.270.85-17.960.190.21-
2022/110.05-11.683.960.77-18.530.150.26-
2022/100.0612.08-38.70.72-19.70.180.22-
2022/90.05-37.28-4.70.66-17.580.280.18-
2022/80.08-47.43-0.880.62-18.460.320.16-
2022/70.1560.9443.290.54-20.520.330.15-
2022/60.099.12-38.350.39-32.160.220.19-
2022/50.09124.43-20.770.29-29.940.180.22-
2022/40.04-32.97-59.390.21-33.080.150.27因疫情影響,進口藥物交期延宕所致
2022/30.067.16-37.630.17-21.950.170.12-
2022/20.05-15.97-13.790.12-11.00.210.1-
2022/10.06-33.53-8.520.06-8.520.20.1-
2021/120.09101.47-31.411.04-24.690.230.13-
2021/110.05-47.93-56.920.94-23.940.190.16因減少合併子公司故本月營收較同期減少
2021/100.0974.25-27.490.9-20.770.220.14-
2021/90.05-34.76-54.660.81-19.940.240.21因減少合併子公司故本月營收較同期減少
2021/80.08-24.0-42.130.76-15.510.330.15-
2021/70.1-30.76-24.150.68-10.70.360.14-
2021/60.1540.2560.170.57-7.790.350.28本月營收:西藥3,743;試劑8,630;租金收入1,034;售電收入697;其他951
2021/50.1115.03-31.430.42-19.940.290.34-
2021/40.092.94-17.70.31-15.070.250.41-
2021/30.0948.12-18.830.22-13.90.220.18-
2021/20.06-10.84-21.660.13-10.090.270.15-
2021/10.07-50.164.330.074.330.320.13本月營收:西藥2,954;租金收入3,270;售電收入639
2020/120.1426.52-22.191.38117.180.370.13本月營收:西藥2,959;租金收入3,005;售電收入512;顧問收入7,295
2020/110.11-12.36177.791.24171.090.350.14因合併子公司,故本月營收較去年同期增加.本月營收:西藥3,694;租金收入3,088;售電收入592;顧問收入3,510
2020/100.128.95281.881.13170.460.380.13因合併子公司,故本月營收較去年同期增加.本月營收:西藥7,919;租金收入2,742;售電收入806;顧問收入952
2020/90.11-16.73235.031.01161.070.390.13因合併子公司,故本月營收較去年同期增加.本月營收:西藥2,785;租金收入2,864;售電收入878;顧問收入4,871
2020/80.14-0.39247.340.89153.920.370.14因合併子公司,故本月營收較去年同期增加.本月營收:西藥4,472;租金收入2,764;售電收入738;其他-口罩286;顧問收入5,429
2020/70.1446.21241.610.76142.140.390.13因合併子公司,故本月營收較去年同期增加.本月營收:西藥4,931;租金收入1,827;售電收入966;顧問收入6,019
2020/60.09-39.96130.310.62127.640.360.19因合併子公司營收,故本月營收較去年同期增加.本月營收:西藥3,660;租金收入2,021;售電收入885;顧問收入2,833
2020/50.1638.08326.010.53127.170.380.18因合併子公司營收,故本月營收較去年同期增加.本月營收:西藥3,373;租金收入2,352;售電收入517;顧問收入9,414
2020/40.111.52669.190.3789.650.30.23因合併子公司營收,故本月營收較去年同期大幅增加.本月營收:西藥1,909;租金收入2,049;售電收入818;顧問收入6,562
2020/30.1142.97128.990.2642.210.260.35因合併子公司營收,故本月營收較去年同期營收增加。本月營收:西藥3,592;租金收入1,758;售電收入756;顧問收入5,062
2020/20.0818.74163.790.149.970.320.28因合併子公司營收,故本月營收較去年同期營收增加,本月營收:西藥2,488;租金收入1,467;售電收入713;顧問收入3,143
2020/10.07-62.83-35.30.07-35.30.280.32本月營收:西藥2,604;租金收入1,980;售電收入720;顧問收入1,274
2019/120.18351.76486.280.6318.160.250.4除本月業績增加外,另因合併子公司營收,故108年12月營收增加
2019/110.0420.4720.850.46-9.710.110.95-
2019/100.03-4.4-25.480.42-11.80.110.94-
2019/90.03-13.67-27.190.39-10.410.111.06-
2019/80.04-2.039.890.35-8.370.121.0-
2019/70.04-1.4212.180.31-10.250.121.02-
2019/60.0411.0413.80.27-12.830.091.84-
2019/50.04149.322.480.23-16.280.11.7-
2019/40.01-69.77-73.570.19-19.080.0N/A係因醫美耗材及儀器租金收入減少之故
2019/30.0564.7-5.130.18-2.640.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)444.76-1.8100.5002.31171.7632.97-31.18-0.080-1.10-0.80
2022 (9)4235.480.03-97.17-0.6400.85-18.2747.91-7.37-0.2400.05-85.290.01-96.88
2021 (8)316.91.060-0.0201.04-24.6451.72-27.770.0200.3400.320
2020 (7)297.41-0.920-0.4101.38119.0571.6057.26-0.080-0.170-0.270
2019 (6)270.0-0.610-0.3600.6316.6745.53191.67-0.160-0.160-0.160
2018 (5)270.0-0.880-0.5900.54-37.2115.61-2.74-0.270-0.230-0.230
2017 (4)270.0-0.390-0.4800.86-51.9616.05-42.41-0.140-0.030-0.10
2016 (3)270.00.080-0.0201.79-26.9427.87-6.570.04100.00.06-40.00.020
2015 (2)270.0-0.130-0.2502.45-18.3329.8310.730.0200.1-47.37-0.030
2014 (1)270.00.570-0.2003.0-61.8326.940-0.0500.1900.150

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。